Back to search
FDAFDA · Food and drugs·Recall number D-0457-2025

Lacosamide Oral Solution, USP, 10 mg/mL, 200 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston FL 33326, NDC 60505-0405-4

Published June 11, 2025 · Recall initiated: May 28, 2025

Summary

FDA records drug Class II recall D-0457-2025, published June 11, 2025 and initiated May 28, 2025. Recalling firm: Apotex Corp.; Status: Ongoing; Reported quantity: 20,648 bottles; Lot: Batch # TZ5589, Exp Date: 01/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container: This recall is being initiated due to a leaking unit stored horizontally.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apotex Corp.
Distributor
US Nationwide.
Lot
Batch # TZ5589, Exp Date: 01/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lacosamide Oral Solution, USP, 10 mg/mL, 200 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston FL 33326, NDC 60505-0405-4 recalled?

Yes. FDA published recall D-0457-2025 on June 11, 2025. Reported hazard: Defective Container: This recall is being initiated due to a leaking unit stored horizontally.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit